Re-irradiation dose escalation for thoracic cancers
Part of Cancer, Digestive system, Lungs & breathing clinical trials.
This trial tests whether giving a higher dose of radiation to the chest (after a previous round of radiation at least 6 months ago) is safe and effective for people with lung cancer, esophageal cancer, or cancer that has spread to the chest. It aims to find the best dose that does not cause severe side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with cancer in the chest (lung, esophagus, or cancer spread from elsewhere).
- You received radiation to the chest at least 6 months ago.
- Your doctor expects you to live longer than 6 months.
- You are able to take care of yourself (ECOG score 0-2).
- You are 18 years or older.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how safe and effective a type of focused radiation called SBRT is for cancer tumors in certain chest locations. It’s meant for people whose tumor is small (up to 5 cm) and who don’t have widespread, uncontrolled spread.
This trial combines a special high-dose radiation (SBRT) with immunotherapy to treat esophageal cancer that has spread to a few spots in the body (up to 5 spots in up to 3 organs). The goal is to see if this approach can better control the cancer.
This study tests whether giving a second course of radiation to the chest (called retreatment) can control lung cancer that has come back or a new cancer that started there. People who have already had radiation to their chest and are healthy enough for more may be eligible.
This trial tests if giving a higher dose of radiation to tumors in the chest (lungs or nearby areas) can better control symptoms or prevent them from getting worse. It is for people who need palliative radiation—treatment aimed at easing discomfort or slowing tumor growth, not curing the cancer.
This study tests whether a single, very high-dose focused radiation treatment can control early-stage lung cancer. It may help people who can’t or prefer not to have surgery, by delivering precise radiation to the tumor while aiming to spare nearby tissue.
This trial tests a higher dose of radiation therapy for people with limited-stage small cell lung cancer (cancer that hasn't spread beyond the chest). It aims to see if the higher dose works better than the standard dose at controlling the cancer.
Hear when a new Thoracic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.